Iatrogenic Botulism Due to Therapeutic Botulinum Toxin A Injection in a Pediatric Patient
Authors:
- Janice E. BrunstromJBJanice E. Brunstrom
- Brad A. RacetteBRBrad A. Racette
- 1 September 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 30 (5) , 310-313
Abstract
Botulinum toxin A is commonly used to reduce spasticity and dystonia in children with cerebral palsy. We report a pediatric patient who developed systemic botulism as a result of a severe overdose of the injected toxin (40 U/kg). This case highlights the importance of physicians having adequate knowledge of primate and human literature on the lethal dose, 50% of botulinum toxin A before injecting children.Keywords
This publication has 21 references indexed in Scilit:
- Neurologic and Developmental Disability at Six Years of Age after Extremely Preterm BirthNew England Journal of Medicine, 2005
- Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical TrialPediatrics, 2001
- Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticityDevelopmental Medicine & Child Neurology, 2001
- Botulinum Toxin as a Biological WeaponJAMA, 2001
- Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsyArchives of Disease in Childhood, 2000
- Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three casesJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Botulinum Toxin A in the Management of Spastic Gait Disorders in Children and Young Adults with Cerebral Palsy: A Randomized, Double-Blind Study of "High-Dose" versus "Low-Dose" Treatment*Neuropediatrics, 1999
- Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Botulinum toxin: Chemistry, pharmacology, toxicity, and immunologyMuscle & Nerve, 1997
- Neuromuscular effects distant from the site of botulinum neurotoxin injectionNeurology, 1988